BG94079A - Олеандомициноксими и метод за получаването им - Google Patents

Олеандомициноксими и метод за получаването им

Info

Publication number
BG94079A
BG94079A BG094079A BG9407991A BG94079A BG 94079 A BG94079 A BG 94079A BG 094079 A BG094079 A BG 094079A BG 9407991 A BG9407991 A BG 9407991A BG 94079 A BG94079 A BG 94079A
Authority
BG
Bulgaria
Prior art keywords
hydrogen
oleandomycinoximes
preparing
line
medicine
Prior art date
Application number
BG094079A
Other languages
English (en)
Other versions
BG60682B1 (bg
Inventor
Gorjana Lazarevski
Slobodan Djokic
Original Assignee
Pliva-Istrazivacki Institut D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Istrazivacki Institut D.O.O. filed Critical Pliva-Istrazivacki Institut D.O.O.
Publication of BG94079A publication Critical patent/BG94079A/bg
Publication of BG60682B1 publication Critical patent/BG60682B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретението намира приложение в медицината за получаване на антимикробни агенти. Олеандомициноксимите имат обща формула в която r1 е водород или -сн3, r2 е -сн3 или водород, или r1 и r2 заедно са епоксидна група или =сн2, r3 е -он, когато линията означава единична връзка, или r3 и линията заедно означават двойна връзка. 8 претенции
BG94079A 1990-03-21 1991-03-20 Олеандомициноксими и метод за получаването им BG60682B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU00556/90A YU55690A (en) 1990-03-21 1990-03-21 Process for preparing oleandomycin oxime

Publications (2)

Publication Number Publication Date
BG94079A true BG94079A (bg) 1993-12-24
BG60682B1 BG60682B1 (bg) 1995-12-29

Family

ID=25550446

Family Applications (1)

Application Number Title Priority Date Filing Date
BG94079A BG60682B1 (bg) 1990-03-21 1991-03-20 Олеандомициноксими и метод за получаването им

Country Status (21)

Country Link
US (1) US5268462A (bg)
EP (1) EP0448035B1 (bg)
JP (1) JP2763972B2 (bg)
CN (1) CN1033645C (bg)
AT (1) ATE132872T1 (bg)
BG (1) BG60682B1 (bg)
CA (1) CA2038629C (bg)
CZ (1) CZ279898B6 (bg)
DE (1) DE69116188T2 (bg)
DK (1) DK0448035T3 (bg)
ES (1) ES2084721T3 (bg)
GR (1) GR3019113T3 (bg)
HR (1) HRP920482B1 (bg)
HU (2) HU207868B (bg)
PL (1) PL166395B1 (bg)
RO (1) RO111769B1 (bg)
RU (1) RU2021281C1 (bg)
SI (1) SI9010556B (bg)
SK (1) SK279105B6 (bg)
UA (1) UA26903C2 (bg)
YU (1) YU55690A (bg)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
RU2256665C1 (ru) * 2004-01-29 2005-07-20 Открытое акционерное общество Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Способ получения оксима эритромицина

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2275459A2 (fr) * 1974-06-21 1976-01-16 Aries Robert Nouveau derive de la rifamycine
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
US4336368A (en) * 1981-04-20 1982-06-22 Pfizer Inc. 4 Deoxy-4-methylene oleandomycin and derivatives thereof
US4429116A (en) * 1982-12-27 1984-01-31 Pfizer Inc. Alkylated oleandomycin containing compounds
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体

Also Published As

Publication number Publication date
HU211574A9 (en) 1995-12-28
CZ279898B6 (cs) 1995-08-16
DK0448035T3 (da) 1996-05-20
CN1033645C (zh) 1996-12-25
EP0448035A1 (en) 1991-09-25
UA26903C2 (uk) 1999-12-29
CA2038629C (en) 1996-09-10
JP2763972B2 (ja) 1998-06-11
PL289507A1 (en) 1992-03-09
RU2021281C1 (ru) 1994-10-15
JPH04234896A (ja) 1992-08-24
ES2084721T3 (es) 1996-05-16
HRP920482B1 (en) 1998-12-31
DE69116188T2 (de) 1996-09-05
ATE132872T1 (de) 1996-01-15
CN1054979A (zh) 1991-10-02
RO111769B1 (ro) 1997-01-30
GR3019113T3 (en) 1996-05-31
HRP920482A2 (en) 1994-08-31
HU207868B (en) 1993-06-28
CA2038629A1 (en) 1991-09-22
BG60682B1 (bg) 1995-12-29
EP0448035B1 (en) 1996-01-10
DE69116188D1 (de) 1996-02-22
CS9100768A2 (en) 1991-11-12
US5268462A (en) 1993-12-07
PL166395B1 (pl) 1995-05-31
SK279105B6 (sk) 1998-06-03
YU55690A (en) 1990-12-31
HUT56848A (en) 1991-10-28
SI9010556B (sl) 1998-10-31
SI9010556A (sl) 1998-04-30

Similar Documents

Publication Publication Date Title
FI970311A0 (fi) Kasvituholaisten torjunta-aineita
FI850078A0 (fi) N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat.
LU91225I2 (fr) Plenaxis
ZA884338B (en) Cyclic amine compound
ES2031523T3 (es) Agentes diureticos de glutaramida espiro-sustituida.
DE69021176D1 (de) Polypeptid und Verfahren zu dessen Herstellung.
EP1245249A3 (fr) Utilisation d'un composé amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
DK0831100T3 (da) Nye peptidderivater
NO913136L (no) Fremgangsmaate for fremstilling av et preparat for oeyedraaper
AR246509A1 (es) Una cetimina, su preparacion y un agente de entrecruzamiento que la contiene.
ATE57833T1 (de) Amosulalolhydrochlorid-formulierungen mit lang anhaltender wirkung.
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
GR3003221T3 (en) Remedy against insects and mites
KR950016727A (ko) 트롬보모듈린 발현을 증가시키는 방법
DE69322872D1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
FI913433A0 (fi) Foerfarande foer foerhindrande eller begraensande av skada vid aoterstroemning av blod genom ett organ eller en vaevnad.
BG94079A (bg) Олеандомициноксими и метод за получаването им
DK640687A (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
ES2021330B3 (es) Ciclohexilaminas fungicidas.
GB1186101A (en) Method of Improving the Properties of Bleached Human Hair and Compositions Therefor
IT8722791A0 (it) Attenuato cosi' ottenuto. procedimento per la preparazione di un ceppo mutante migliorato di bordetella bronchiseptica utile per un vaccino attenuato vivo per la protezione da infezioni di b.bronchiseptica e vaccino ar vivo
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
ES8704912A1 (es) Procedimiento para la obtencion de n-(3-cloro-1,2,4-oxadia- zol-5-il)-ureas
DE59402136D1 (de) Intravenös verabreichbare wässrige Lösung von Sulfametrol und Trimethoprim
KR970006280A (ko) 신규 2-클로로-3-치환아미노-1,4-나프탈렌디온 유도체